Biomutant, the open world RPG from Experiment 101, has sold over one million copies and made its development costs back within its opening week.
As confirmed by the developer's parent company Embracer Group in its Q1 interim report, Biomutant acted as a key contributor to sales and revenue generated in the quarter.
Embracer Group confirmed the success of Biomutant in the report. "The main revenue driver in the quarter was the release of Biomutant from our internal studio Experiment 101." the report states. "So far, the game has sold more than one million copies. The full investment into development and marketing as well as the acquisition cost for Experiment 101 and the IP, was recouped within a week after launch," added Embracer Group.
Embracer Group said that it is pleased with its organic year-over-year growth which is supported by a wide back catalog and strong contribution from new releases. Overall, the net sales and operational EBIT performance of the first quarter set new records in line with the company's expectations. In addition to the release of Biomutant, Embracer Group also cited the addition of Easybrain and Gearbox as contributors to this success.
Despite Biomutant's financial success, the game launched with a number of performance problems across PlayStation and Xbox which ranged from low-quality textures to issues with framerate. Following community feedback, Experiment 101 has tweaked a wide range of aspects within the game across a number of subsequent patches. Aside from various bug fixes and tweaks, the developer has made additional changes to combat, loot variation, UI, quests, and even the game's narrator. The latest patch notes for Biomutant were tweeted out by the developer in June.
If you're currently playing through Experiment 101's mutant martial arts RPG, then make sure to check out our Biomutant review. For more on the game, you can take a scroll through our dedicated Biomutant page which features a range of the title's latest news.
Jared Moore is a freelance writer for IGN. You can follow him on Twitter.
Continue reading...
As confirmed by the developer's parent company Embracer Group in its Q1 interim report, Biomutant acted as a key contributor to sales and revenue generated in the quarter.
Embracer Group confirmed the success of Biomutant in the report. "The main revenue driver in the quarter was the release of Biomutant from our internal studio Experiment 101." the report states. "So far, the game has sold more than one million copies. The full investment into development and marketing as well as the acquisition cost for Experiment 101 and the IP, was recouped within a week after launch," added Embracer Group.
Embracer Group said that it is pleased with its organic year-over-year growth which is supported by a wide back catalog and strong contribution from new releases. Overall, the net sales and operational EBIT performance of the first quarter set new records in line with the company's expectations. In addition to the release of Biomutant, Embracer Group also cited the addition of Easybrain and Gearbox as contributors to this success.
Despite Biomutant's financial success, the game launched with a number of performance problems across PlayStation and Xbox which ranged from low-quality textures to issues with framerate. Following community feedback, Experiment 101 has tweaked a wide range of aspects within the game across a number of subsequent patches. Aside from various bug fixes and tweaks, the developer has made additional changes to combat, loot variation, UI, quests, and even the game's narrator. The latest patch notes for Biomutant were tweeted out by the developer in June.
If you're currently playing through Experiment 101's mutant martial arts RPG, then make sure to check out our Biomutant review. For more on the game, you can take a scroll through our dedicated Biomutant page which features a range of the title's latest news.
Jared Moore is a freelance writer for IGN. You can follow him on Twitter.
Continue reading...